PeerJ 12, e18227
A: Yes, it enhances and maintains injection results
Poster Session I - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.05 - NEUROINTERVENTION P083 - ESOC25-231 COMORBIDITY BURDEN AND OUTCOMES AFTER ENDOVASCULAR THROMBECTOMY FOR MEDIUM VESSEL OCCLUSIONS Emma Hall 1 , Johan Wasselius 1 , Mats Pihlsgrd 2 , Teresa Ullberg 3 , Bjrn Hansen 1 1 Diagnostic Radiology, Department of Clinical Science, Lund, Sweden, 2 Perinatal and Cardiovascular Epidemiology, Department of Clinical Science, Malm, Sweden, 3 Department of Neurology, Department of Clinical Science, Malm, Sweden Background and Aims: Patients with severe comorbidities are underrepresented in the ongoing randomized endovascular thrombectomy (EVT) trials for medium vessel occlusions (MeVOs)
Abbreviations KOA: Knee osteoarthritis LPS: Lipopolysaccharide FLS: Fibroblast-like synoviocytes AMPK: AMP-activated protein kinase CPT1: Carnitine palmitoyltransferase 1 Cyc: Cytochrome c ACLT: Anterior cruciate ligament transection NSAIDs: Non-steroidal anti-inflammatory drugs CoA: Coenzyme A SOD: Superoxide dismutase MDA: Malonaldehyde ATP: Adenosine-triphosphate ROS: Reactive oxygen species CCK-8: Cell counting kit-8 DMEM: Dulbeccos modified Eagles medium IL-1: Interleukin-1 siRNA: Small interfering RNA References Sharma L
